Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials

Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials

Item
http://www.wikidata.org/entity/Q26858830
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.Is ovarian cancer a targetable disease? A systematic review and meta-analysis and genomic data investigationFatty acid synthase overexpression: target for therapy and reversal of chemoresistance in ovarian cancer.Nanoreporter PET predicts the efficacy of anti-cancer nanotherapy.A liposomal formulation of the synthetic curcumin analog EF24 (Lipo-EF24) inhibits pancreatic cancer progression: towards future combination therapies.Improved Targeting of Cancers with Nanotherapeutics.Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysisInteraction of adriamycin with a regulatory element of hmgb1: spectroscopic and calorimetric approach.In vivo study of doxorubicin-loaded cell-penetrating peptide-modified pH-sensitive liposomes: biocompatibility, bio-distribution, and pharmacodynamics in BALB/c nude mice bearing human breast tumors.A dual-channel endoscope for quantitative imaging, monitoring, and triggering of doxorubicin release from liposomes in living mice.Anticoagulants Influence the Performance of In Vitro Assays Intended for Characterization of Nanotechnology-Based Formulations.Topoisomerases as anticancer targets.Absence of cardiotoxicity with prolonged treatment and large accumulating doses of pegylated liposomal doxorubicin.Monepantel considerably enhances the therapeutic potentials of PEGylated liposomal doxorubicin and gemcitabine in ovarian cancer: in vitro and in vivo studies
P2860

Pegylated liposomal doxorubicin in the management of ovarian cancer: a systematic review and metaanalysis of randomized trials

Item
http://www.wikidata.org/entity/Q26858830
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@ast
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@en
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@nl
type
label
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@ast
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@en
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@nl
prefLabel
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@ast
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@en
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@nl
P1433
P1476
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P3181
P356
P1433
P1476
Pegylated liposomal doxorubici ...... aanalysis of randomized trials
@en
P2093
P2860
P304
P31
P3181
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932